Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis. (2019)
Attributed to:
Bridging epigenetics, metabolism and cell cycle in pathogenic trypanosomatids
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2019.00657
PubMed Identifier: 31281253
Publication URI: http://europepmc.org/abstract/MED/31281253
Type: Journal Article/Review
Volume: 10
Parent Publication: Frontiers in pharmacology
ISSN: 1663-9812